Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $117

Benzinga · 15h ago
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $117.